Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
Sage Therapeutics (NASDAQ: SAGE) has scheduled its first quarter 2025 financial results announcement and business updates for Tuesday, April 29, 2025, at 4:30 p.m. ET. The company will host a live webcast accessible through their investor relations website at investor.sagerx.com. The webcast recording will remain available for up to 30 days after the event.
Sage Therapeutics (NASDAQ: SAGE) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 e gli aggiornamenti aziendali per martedì 29 aprile 2025, alle 16:30 ET. La società trasmetterà una diretta web accessibile tramite il sito per gli investitori all'indirizzo investor.sagerx.com. La registrazione della diretta sarà disponibile per un massimo di 30 giorni dopo l'evento.
Sage Therapeutics (NASDAQ: SAGE) ha programado el anuncio de los resultados financieros del primer trimestre de 2025 y las actualizaciones comerciales para el martes 29 de abril de 2025 a las 4:30 p.m. ET. La compañía realizará una transmisión en vivo accesible a través de su sitio web para inversores en investor.sagerx.com. La grabación de la transmisión estará disponible hasta 30 días después del evento.
Sage Therapeutics (NASDAQ: SAGE)는 2025년 1분기 재무 실적 발표 및 사업 업데이트를 2025년 4월 29일 화요일 오후 4시 30분(동부 시간)에 예정하고 있습니다. 회사는 투자자 관계 웹사이트 investor.sagerx.com을 통해 실시간 웹캐스트를 진행할 예정입니다. 웹캐스트 녹화 영상은 행사 후 최대 30일간 시청할 수 있습니다.
Sage Therapeutics (NASDAQ : SAGE) a programmé l'annonce des résultats financiers du premier trimestre 2025 ainsi que des mises à jour commerciales pour le mardi 29 avril 2025 à 16h30 ET. La société diffusera un webinaire en direct accessible via son site dédié aux investisseurs à l'adresse investor.sagerx.com. L'enregistrement du webinaire restera disponible pendant 30 jours après l'événement.
Sage Therapeutics (NASDAQ: SAGE) hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 sowie Geschäftsupdates für Dienstag, den 29. April 2025, um 16:30 Uhr ET geplant. Das Unternehmen wird ein Live-Webcast anbieten, der über die Investor-Relations-Website investor.sagerx.com zugänglich ist. Die Aufzeichnung des Webcasts wird bis zu 30 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414189773/en/
Investor Contact
Ashley Kaplowitz
ashley.kaplowitz@sagerx.com
Media Contact
Francesca Dellelci
francesca.dellelci@sagerx.com
Source: Sage Therapeutics, Inc.
FAQ
When will Sage Therapeutics (SAGE) report Q1 2025 earnings?
How can investors access SAGE's Q1 2025 earnings webcast?
How long will SAGE's Q1 2025 earnings webcast replay be available?
What information will be covered in SAGE's Q1 2025 earnings call?
